Selective Immunoaffinity-Based Enrichment of CD34+Cells Transduced with Retroviral Vectors Containing an Intracytoplasmatically Truncated Version of the Human Low-Affinity Nerve Growth Factor Receptor (ΔLNGFR) Gene
- 10 October 1997
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 8 (15), 1815-1824
- https://doi.org/10.1089/hum.1997.8.15-1815
Abstract
Human hematopoietic stem cells remain one of the most promising target cells for gene therapeutic approaches to treat malignant and nonmalignant diseases. To rapidly characterize transduced cells and to isolate these from residual nontransduced, but biologically equivalent, cells, we have used a Moloney murine leukemia virus (Mo-MuLV)-based retroviral vector containing the intracytoplasmatically truncated human low-affinity nerve growth factor receptor (ΔLNGFR) cDNA as a marker gene. Supernatant transduction of CD34+ cells (mean purity 97%) in fibronectin-coated tissue culture flasks resulted in 5.5–45% (mean 26%) transduced cells expressing ΔLNGFR (LNGFR+ cells). After transduction, more than 65% of the transduced cells remained CD34+. Compared with control (mock- and nontransduced) CD34+ cells, transduction did not decrease the cloning efficiency of CD34+ cells. Immunomagnetic selection of the transduced cells with a monoclonal anti-LNGFR antibody resulted in >90% LNGFR+ cells. Further phenotypic characterization of these highly enriched LNGFR+ cells indicated that the majority co-expressed the CD34 and CD38 antigens. These results show that transduced cells expressing an ectopic cell-surface protein can be rapidly and conveniently quantitated and characterized by fluorescence-activated cell sorting (FACS) analysis and fast and efficiently enriched by immunoadhesion using magnetic beads. The use of cell-surface reporters should facilitate optimization of methods of gene transfer into more primitive hematopoietic progenitors. In the present study, primary human CD34+ cells as well as TF-1 cells have been efficiently transduced using a Moloney murine leukemia virus (Mo-MLV) vector containing a truncated version of the human low-affinity nerve growth factor receptor gene (ΔLNGFR). Fast and convenient quantitation of the transduction efficiency by fluorescence-activated cell sorting (FACS) analysis as well as enrichment of transduced cells by immunoadhesion were possible through the ectopically expressed transgene. Expression of ΔLNGFR in hematopoietic progenitor cells will be a useful tool for the selection of transgene-expressing cells and for the design of novel and further development of existing retroviral vectors because gene transfer efficiency can be measured almost immediately after transduction.Keywords
This publication has 41 references indexed in Scilit:
- HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-LeukemiaScience, 1997
- Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA − Immunodeficient PatientsScience, 1995
- Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors.JCI Insight, 1994
- High Efficiency Retroviral-Mediated Gene Transduction into CD34+Cells Purified from Peripheral Blood of Breast Cancer Patients Primed with Chemotherapy and Granulocyte-Macrophage Colony-Stimulating FactorHuman Gene Therapy, 1994
- Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patientsThe Lancet, 1993
- Human gene therapy comes of ageNature, 1992
- Safety Issues Related to Retroviral-Mediated Gene Transfer in HumansHuman Gene Therapy, 1991
- Comparison of the Effects of Growth Factors on Retroviral Vector-Mediated Gene Transfer and the Proliferative Status of Human Hematopoietic Progenitor CellsHuman Gene Therapy, 1990
- Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietinJournal of Cellular Physiology, 1989
- Construction and use of a safe and efficient amphotropic packaging cell lineVirology, 1988